These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28460544)

  • 1. Pulmonary vascular resistance index during coronary artery bypass surgery with aprotinin.
    Toikkanen V; Rinne T; Laurikka J; Porkkala H; Tarkka M; Mennander A
    Scand J Clin Lab Invest; 2017 Sep; 77(5):315-320. PubMed ID: 28460544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiopulmonary bypass decreases pulmonary vascular resistance index after coronary artery bypass surgery.
    Toikkanen V; Rinne T; Huhtala H; Laurikka J; Porkkala H; Tarkka M; Mennander A
    Scand J Clin Lab Invest; 2014 Jan; 74(1):37-43. PubMed ID: 24266780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of aprotinin and pentoxifylline in preventing leukocyte sequestration and lung injury caused by protamine at the end of cardiopulmonary bypass surgery.
    Ege T; Arar C; Canbaz S; Cikirikcioglu M; Sunar H; Yuksel V; Duran E
    Thorac Cardiovasc Surg; 2004 Feb; 52(1):10-5. PubMed ID: 15002070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aprotinin Impacts 8-Isoprostane after Coronary Artery Bypass Grafting.
    Toikkanen V; Rinne T; Nieminen R; Moilanen E; Laurikka J; Porkkala H; Tarkka M; Mennander AA
    Scand J Surg; 2018 Dec; 107(4):329-335. PubMed ID: 29628009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
    Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does high-dose methylprednisolone in aprotinin-treated patients attenuate the systemic inflammatory response during coronary artery bypass grafting procedures?
    Tassani P; Richter JA; Barankay A; Braun SL; Haehnel C; Spaeth P; Schad H; Meisner H
    J Cardiothorac Vasc Anesth; 1999 Apr; 13(2):165-72. PubMed ID: 10230950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of aprotinin against lung damage in patients undergoing CABG surgery.
    Erdogan M; Kalaycioglu S; Iriz E
    Acta Cardiol; 2005 Aug; 60(4):367-72. PubMed ID: 16128368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does a hyperoncotic cardiopulmonary bypass prime affect extravascular lung water and cardiopulmonary function in patients undergoing coronary artery bypass surgery?
    Eising GP; Niemeyer M; Günther T; Tassani P; Pfauder M; Schad H; Lange R
    Eur J Cardiothorac Surg; 2001 Aug; 20(2):282-9. PubMed ID: 11463545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does aprotinin reduce lung reperfusion damage after cardiopulmonary bypass?
    Rahman A; Ustünda B; Burma O; Ozercan IH; Cekirdekçi A; Bayar MK
    Eur J Cardiothorac Surg; 2000 Nov; 18(5):583-8. PubMed ID: 11053821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of hyperoncotic cardiopulmonary bypass prime on extravascular lung water and cardiopulmonary function in patients undergoing coronary artery bypass surgery].
    Jin X; Chen Z; Wang M; Lü W; Zhang W; Sun J
    Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(9):646-50. PubMed ID: 24842200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Low-dose" aprotinin modifies hemostasis but not proinflammatory cytokine release.
    Ashraf S; Tian Y; Cowan D; Nair U; Chatrath R; Saunders NR; Watterson KG; Martin PG
    Ann Thorac Surg; 1997 Jan; 63(1):68-73. PubMed ID: 8993243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney-specific proteins in patients receiving aprotinin at high- and low-dose regimens during coronary artery bypass graft with cardiopulmonary bypass.
    Faulí A; Gomar C; Campistol JM; Alvarez L; Manig AM; Matute P
    Eur J Anaesthesiol; 2005 Sep; 22(9):666-71. PubMed ID: 16163912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose aprotinin modulates the balance between proinflammatory and anti-inflammatory responses during coronary artery bypass graft surgery.
    Tassani P; Augustin N; Barankay A; Braun SL; Zaccaria F; Richter JA
    J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):682-6. PubMed ID: 11139109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of ventilation during cardiopulmonary bypass in the prevention of postoperative lung dysfunction.
    Gagnon J; Laporta D; Béïque F; Langlois Y; Morin JF
    Perfusion; 2010 Jul; 25(4):205-10. PubMed ID: 20605871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aprotinin decreases the incidence of cognitive deficit following CABG and cardiopulmonary bypass: a pilot randomized controlled study.
    Harmon DC; Ghori KG; Eustace NP; O'Callaghan SJ; O'Donnell AP; Shorten GD
    Can J Anaesth; 2004 Dec; 51(10):1002-9. PubMed ID: 15574551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low dose aprotinin and low dose tranexamic acid in elective cardiac surgery with cardiopulmonary bypass.
    Waldow T; Krutzsch D; Wils M; Plötze K; Matschke K
    Clin Hemorheol Microcirc; 2009; 42(4):269-77. PubMed ID: 19628892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of N-acetylcysteine on pulmonary function in patients undergoing coronary artery bypass surgery with cardiopulmonary bypass.
    Eren N; Cakir O; Oruc A; Kaya Z; Erdinc L
    Perfusion; 2003 Nov; 18(6):345-50. PubMed ID: 14714769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulsatile pulmonary perfusion with oxygenated blood ameliorates pulmonary hemodynamic and respiratory indices in low-risk coronary artery bypass patients.
    Santini F; Onorati F; Telesca M; Patelli F; Berton G; Franchi G; Faggian G; Mazzucco A
    Eur J Cardiothorac Surg; 2011 Oct; 40(4):794-803. PubMed ID: 21388821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary abnormalities after coronary arterial bypass grafting operation: cardiopulmonary bypass versus mechanical stabilization.
    Kochamba GS; Yun KL; Pfeffer TA; Sintek CF; Khonsari S
    Ann Thorac Surg; 2000 May; 69(5):1466-70. PubMed ID: 10881824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategic leukocyte depletion reduces pulmonary microvascular pressure and improves pulmonary status post-cardiopulmonary bypass.
    Olivencia-Yurvati AH; Ferrara CA; Tierney N; Wallace N; Mallet RT
    Perfusion; 2003 Mar; 18 Suppl 1():23-31. PubMed ID: 12708762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.